Hamptons Center for Regenerative Medicine Review: Following the GLP-1 Care Handoffs

A GLP-1 program can look like one service while involving several separate organizations. That distinction is central to Hamptons Center for Regenerative Medicine: its website presents a physician-led longevity practice, but its terms describe Hamptons Longevity LLC as a technology platform connecting patients with independent clinicians and pharmacies. For a prospective patient, the practical question is not simply whether a prescription is available. It is who evaluates the application, prepares the medicine, answers treatment questions and takes responsibility when something needs attention.

Public pages consulted October 19, 2026 document compounded injectable semaglutide and tirzepatide programs, a separate GLP-1 Microdose offering, online or Long Island evaluations, home delivery and continuing support. They also contain conflicting cancellation language and qualifications to broad nationwide-access and privacy claims. This review follows the documented service from enrollment through follow-up, separating advertised features from contractual responsibilities. Our guide to clinician and platform roles provides additional context for understanding this kind of divided care arrangement.

At a glance

Who operates the website: Hamptons Longevity LLC owns the domain and says it is a technology platform, not the entity practicing medicine or preparing or dispensing prescriptions.
Sources: [7]
Advertised injectable prices: Compounded semaglutide injection starts at $139 per month and compounded tirzepatide injection at $149 per month. Pricing is subject to provider review; the duration of these starting rates is not established.
Sources: [9] [10]
Documented care pathway: An online or Long Island evaluation precedes treatment authorization, partner-pharmacy preparation, direct delivery and structured check-ins with portal messaging.
Sources: [10]
Cancellation conflict: The terms specify turning off auto-refill at least 48 hours before monthly processing; treatment FAQs instead require 30 days’ notice before the next billing cycle.
Sources: [7] [10]
Location restrictions: Despite nationwide telehealth advertising, the terms limit access to operating states and require patients to be physically in the state matching their recorded shipping address during consultation.
Sources: [9] [7]

Start by identifying the organizations behind the service

The brand describes itself as a physician-led longevity practice serving Long Island and telehealth patients. Its broader menu includes hormone optimization, peptides, individualized IV infusions, body contouring, facial rejuvenation and regenerative services. Those offerings establish the business’s wider focus; they do not establish that any accompanying service is necessary for a GLP-1 patient. The GLP-1 pathway should be evaluated on its own documented clinical, pharmacy and support arrangements rather than on the breadth of that menu.

The contractual description is more specific about responsibility. Hamptons Longevity LLC owns and operates the website but says it does not practice medicine, provide clinical care, prepare or dispense medications, or control independent professionals’ judgment. A site notice describes access to independent, U.S. board-certified clinical providers and state-licensed compounding pharmacies. Those are provider representations, not credentials independently verified for this review.

The consulted documentation does not name the treating clinicians, medical groups or dispensing pharmacies. Before enrolling, a useful request is the identity of each organization that will handle the account, consultation and prescription, along with its contact route. That information would make the advertised integrated experience easier to navigate if a billing question belongs to the platform while a treatment question belongs to a clinician or pharmacist.

Sources: [7] [3] [9] [10]

Intake establishes a request for care, not an approval

The advertised entry point is a short online assessment covering health goals and basic medical history. A licensed clinician reviews the information and creates a plan only if clinically appropriate. Treatment pages also offer an evaluation at the Long Island office. Their FAQs say a licensed physician reviews and authorizes the consultation. These descriptions support a clinician-reviewed process, but they do not establish whether every applicant receives a live video appointment or how quickly review occurs.

For both semaglutide and tirzepatide, the site publishes starting criteria of adulthood, with a BMI of 27 or higher, or 25 or higher with weight-related conditions. These are the provider’s stated criteria, not a guarantee of treatment. The tirzepatide page also lists exclusions involving personal or family history of medullary thyroid carcinoma or MEN 2, pregnancy, breastfeeding or planned pregnancy, active pancreatitis, and untreated severe gastrointestinal disease.

The site says the clinical team reviews history, labs and goals, yet does not establish mandatory tests, testing intervals or lab charges. Applicants should ask whether existing results are acceptable and what happens if additional testing is requested. Preparing a medication list and relevant history using our first-consultation guide can help make that discussion more concrete without trying to determine eligibility independently.

Sources: [9] [10] [4]

Confirm state access before arranging the consultation

The homepage advertises nationwide telehealth, but the terms do not establish availability in all 50 states. They limit service to states where Hamptons Longevity LLC operates and to people at least 18, or the local age of majority if higher. No complete state-by-state availability list or product-specific map is established in the consulted material. Confirming access for the intended program is therefore a practical first step, not something to infer from the national advertising.

Another contractual requirement concerns the patient’s physical location: during consultation, it must match the state of the shipping address in the account. Someone traveling or temporarily staying elsewhere should ask how that rule affects scheduling and delivery before completing a consultation. The restriction concerns where the patient is located, not simply which address appears on a payment card.

For direct inquiries, the contact page lists 89 Forest Road, Centereach, NY 11720; telephone (631) 496-1102; and info@hamptonslongevity.center. Published clinical hours are Monday through Friday, 9 a.m. to 5 p.m., without a stated time zone in that block. The contact form promises a response within 24 hours. That is an inquiry-response claim, not a documented deadline for prescription approval, clinical review or urgent treatment advice.

Sources: [9] [7] [8]

The prescription leads to a restricted pharmacy channel

The treatment pages describe compounded medication prepared by partner pharmacies and shipped on a structured cadence. They say practitioners may prescribe customized formulations when commercially available treatments do not meet an individual patient’s needs. The terms assign direct shipment to the applicable pharmacy after consultation and dispensing. They also require purchasers of prescription-inclusive services to waive filling the prescription at a pharmacy of their own choice, a meaningful limitation for anyone hoping to use an existing local pharmacy.

Compounded preparations are not FDA approved and do not undergo FDA premarket review for safety, effectiveness and quality. FDA recommends them when an individual’s medical needs cannot be met by an FDA-approved drug, with a prescription and a state-licensed pharmacy. Nonapproval alone does not establish clinical inequivalence. It also does not make trial results for approved products evidence of outcomes for this platform’s compounded preparations.

The separate GLP-1 Microdose program is promoted for metabolic health, body composition and appetite recalibration rather than aggressive weight loss. The site describes prospective users near goal weight, those who previously tolerated standard GLP-1 dosing poorly, and people incorporating hormone or peptide plans. Those are marketing descriptions, not verified benefits or individualized recommendations. The consulted text does not identify Microdose’s active ingredient, route or price. Our pharmacy-handoff guide outlines useful questions about the actual prescribed product.

Sources: [10] [7] [6] [1]

Separate the subscription payment from the clinical milestones

The homepage advertises compounded semaglutide injection from $139 per month and compounded tirzepatide injection from $149 per month. Their cards also show $249 and $299, respectively, without explaining those additional figures in the quoted blocks. The general starting price is confirmed after provider review. The documentation does not establish how long the starting rates last, the quantity supplied per payment or whether those secondary figures represent subsequent charges.

Prescription, discreet delivery and continuing check-ins appear on the product cards. Treatment pages claim flat-rate pricing with no hidden fees, consultation charges or dose-change surcharges. The terms describe a bundle covering the pharmacy’s prescription charge, the medical group’s services and platform access. These statements are useful, but the final quote should still identify any required laboratory expense because the consulted pages do not settle that question.

For recurring monthly orders, the terms authorize an immediate charge and another every 30 days until cancellation, with electronic notice five to seven days before a scheduled transaction. That is a 30-day billing interval, not necessarily a calendar month or a documented quantity of medication. The homepage also advertises $0 if not approved and no insurance required; neither statement establishes insurance billing, reimbursement paperwork or HSA/FSA acceptance.

What the advertised payment and delivery terms establish
Item	Documented term	Still needs confirmation
Compounded semaglutide injection	From $139 per month; $249 also displayed	Starting-rate duration, secondary figure and quantity
Compounded tirzepatide injection	From $149 per month; $299 also displayed	Starting-rate duration, secondary figure and quantity
Recurring payment	Immediate charge, then every 30 days	Final product-specific amount
Bundled services	Prescription, medical-group services and platform access	Required lab costs, if any
Shipping	Free 2–3 day shipping advertised	Preparation time and total arrival timeline

Sources: [9] [10] [7]

Delivery has more than one clock

The homepage advertises free two-to-three-day shipping. Treatment pages describe unmarked, temperature-controlled packaging delivered to the patient’s door. Those promises concern logistics, not the entire interval from application to receipt. Clinical review, any requested testing, authorization, pharmacy preparation and transport are separate stages. The documentation does not give a total turnaround time or specify when the advertised shipping clock starts, so it should not be read as a two-to-three-day treatment-start guarantee.

The terms also warn that prescriptions may not use child-resistant packaging and that prescription products will not be dispensed in child-resistant containers. Discreet packaging and temperature control do not resolve that separate storage concern. Before delivery, patients can ask the dispensing pharmacy about package contents, labeling, storage instructions and the appropriate contact if the shipment appears damaged or its temperature handling is uncertain.

FDA explicitly advises not using an injectable GLP-1 medicine that arrives warm or with insufficient refrigeration, and contacting the provider or dispensing pharmacy to resolve concerns. That advice is general regulatory guidance, not evidence of a shipping problem at Hamptons. The practical question for this program is which organization handles replacement, shipment review and related charges. Our guide to warm injectable deliveries explains the FDA advice without substituting for pharmacy instructions.

Sources: [9] [10] [7] [1]

Follow-up access is documented, but its schedule is not

The program promises structured check-ins and direct messaging with the care team through a secure patient portal between appointments. The homepage says follow-ups are scheduled as needed so the plan can be adjusted over time. Together, these statements document continuing access rather than a prescription-only transaction. They do not establish a universal appointment frequency, a clinical-message response deadline or whether the same professional follows a patient throughout treatment.

Before paying, ask who monitors portal messages, how questions reach the prescriber and how the team distinguishes routine support from issues requiring prompt evaluation. The published weekday clinical hours and 24-hour contact-form response should not be treated as round-the-clock clinical coverage. NIDDK describes follow-up as addressing treatment response and tolerability, not merely renewing payments. FDA also reports measurement and administration errors with compounded medication, making clear product-specific instructions from the prescriber or pharmacist important.

The documentation has a separate privacy tension. Treatment FAQs say medical information goes only to the physician and dispensing pharmacy and broadly promise never to sell or share data. The terms say the company is not a HIPAA covered entity, although it may sometimes act as a business associate. A California notice permits certain advertising-related disclosures that may count as a sale or sharing under state law. These statements concern different roles and data categories; the broad FAQ promise is not the whole privacy picture.

Sources: [10] [9] [8] [7] [5] [2] [1]

Clarify the exit process before the first renewal

The most consequential contractual inconsistency concerns cancellation. The homepage says “Cancel anytime.” The terms allow cancellation by disabling auto-refill in the portal at least 48 hours before monthly processing. Treatment FAQs instead require 30 days’ notice before the next billing cycle. Those are materially different deadlines. A patient cannot reliably plan an exit from the slogan alone, and the consulted documentation does not resolve which rule controls a particular purchase.

Refund language is separate: consultations, medical visits and fulfilled prescriptions are described as nonrefundable once services begin or medication is processed. Canceling a future refill therefore does not establish a right to reimbursement for an earlier payment. Before authorizing recurring charges, request written confirmation of the applicable cancellation deadline, the effective end date, what happens to an already-processing order and how cancellation will be acknowledged.

Ending a subscription also leaves a care question: how to obtain records, communicate unresolved concerns and arrange any further clinical discussion. The public documentation does not establish a detailed transition process. That gap matters because payment cancellation and treatment planning are different responsibilities. The useful pre-enrollment goal is a written account of both: what stops future billing and which clinician remains available to answer questions about the existing prescription.

Sources: [9] [7] [10]

Questions & answers

Is Hamptons Longevity LLC itself my medical provider?

Its terms say no: the company operates a technology platform and does not provide clinical care or dispense medication. The brand separately describes a physician-led practice and access to independent clinicians. Ask for the actual treating professional, medical group and dispensing pharmacy before enrolling; their names and credentials were not established in the consulted documentation.

Sources: [7] [3] [9]

Are the $139 and $149 prices guaranteed ongoing rates?

No ongoing guarantee is established. They are advertised starting monthly prices for compounded semaglutide injection and compounded tirzepatide injection, respectively, subject to provider review. The cards also display $249 and $299 without explaining their role. Obtain the initial charge, subsequent charge, supplied quantity and any rate-duration conditions in writing rather than assuming the starting amount applies indefinitely.

Sources: [9] [10]

Can I send the prescription to my usual pharmacy?

The terms require purchasers of prescription-inclusive services to waive filling at a pharmacy of their choice. They describe fulfillment through participating pharmacies, with direct shipment by the applicable pharmacy. If outside-pharmacy access matters to you, ask whether another arrangement is available before purchasing; the public documentation does not establish such an option or name the participating pharmacies.

Sources: [7]

Does two-to-three-day shipping mean treatment arrives that soon after applying?

That is not established. The advertised shipping interval does not include a documented allowance for clinical review, testing or pharmacy preparation. The site offers temperature-controlled, unmarked delivery, but no complete application-to-arrival timetable. Ask when the shipping clock begins, how tracking is provided and whom to contact if approval or fulfillment takes longer than expected.

Sources: [9] [10]

What is known about the GLP-1 Microdose program?

The site markets it for metabolic health, body composition and appetite recalibration, and describes several prospective patient groups. The consulted description does not identify the active ingredient, administration route or specific price. Its positioning should not be mistaken for demonstrated benefits in this program. Ask for the exact prescribed product, rationale, monitoring plan and full charge before evaluating it as a distinct offering.

Sources: [6]

How much notice is required to stop recurring charges?

The public documents conflict. Terms specify disabling auto-refill at least 48 hours before monthly processing; treatment FAQs require 30 days’ notice before the next billing cycle. Ask which applies to your purchase and retain written confirmation. Also distinguish stopping future charges from obtaining a refund: services already begun and medication already processed have separate nonrefundability language.

Sources: [7] [10]

Our assessment

Hamptons documents a recognizable care pathway: assessment, clinician authorization, partner-pharmacy preparation, home delivery and ongoing portal access. Its advertised bundle and absence of consultation or dose-change surcharges could make the service easier to understand once an individualized quote is issued. The principal weakness is not a lack of advertised features but incomplete clarity at the handoffs. Clinician and pharmacy identities, state access, total turnaround time, lab requirements and follow-up frequency remain unresolved, while cancellation and privacy language need reconciliation. Before enrolling, seek a written service summary identifying the responsible organizations, exact compounded product, initial and renewal charges, shipping expectations and applicable cancellation deadline. Those answers would provide a firmer basis for evaluating the service than its starting price or longevity branding alone.

Visit Hamptons Center for Regenerative Medicine’s official site ↗

This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.

FOLLOW THE EVIDENCE

Research behind treatment claims

Use these studies to assess the type of outcome a treatment claim describes. They did not test this provider or establish results for its products.

SURMOUNT-5: What a Direct Weight-Loss Comparison Can—and Cannot—Tell You About Ongoing Care
Tirzepatide produced greater average weight and waist reductions than semaglutide over 72 weeks. Understanding the trial’s design matters just as much as understanding the difference.
After the Weight Loss: What SURMOUNT-4 Means for Continuity of Care
Randomized tirzepatide withdrawal separates maintaining a treatment effect from finishing a course. Reading its two baselines—and newer maintenance-dose research—shows what the evidence can and cannot tell patients changing care.

Explore the science library →

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

Hamptons Center for Regenerative Medicine Review: Following the GLP-1 Care Handoffs

At a glance

01Start by identifying the organizations behind the service

02Intake establishes a request for care, not an approval

03Confirm state access before arranging the consultation

04The prescription leads to a restricted pharmacy channel

05Separate the subscription payment from the clinical milestones

06Delivery has more than one clock

07Follow-up access is documented, but its schedule is not

08Clarify the exit process before the first renewal